India records over 400,000 Covid cases in 24 hours
Demonstrators hold oxygen cylinders as they shout slogans against the lawmakers during a protest over the shortage of oxygen cylinders amid Covid-19 coronavirus pandemic in Amritsar.–AFP
According to the health ministry, 401,993 new infections were registered taking the total caseload to 19.1 million. There were 3,523 deaths, bringing the toll to 211,853.
Many experts suspect that because of insufficient testing and inaccurate recording of cause of death, the real numbers are much higher.
Indian authorities lowered their guard in the early part of the year after infections fell below 10,000 per day, lifting restrictions on most activity.
Mass religious gatherings such as the Kumbh Mela, attracting millions of Hindu pilgrims, and political rallies were allowed to continue even when cases numbers began rising sharply in late March.
Faltering vaccine drive
Indian authorities lowered their guard in the early part of the year after infections fell, lifting restrictions on most activity and allowing mass religious and political gatherings to take place.
Less then two months after the health minister said India was in the "end game" of the pandemic and New Delhi sent millions of vaccines abroad, the surge has sent worried Indians rushing for the jabs still in the country.
A crowd of around 100 people formed outside one Delhi hospital on Saturday as a hospital attendant came out regularly to call out numbers to people who had booked.
"There are so many people that are getting sick and if we get better we ensure that other people... do not get infected so we just wanted to be here as soon as possible," said one of those waiting, Aadya Mehta, 25.
Until now, only "frontline" workers like medical staff, people over 45 and those with existing illnesses have been given vaccines.
But even this more modest programme has stumbled, with some areas running out of shots and others throwing them away because of a lack of demand, in part because of the recent surge.
"The queues here are so colossal," said Jayanti Vasant as he waited for hours at a busy vaccination centre in Mumbai this week. "The people are just fighting amongst themselves."
So far around 150 million shots have been administered, equating to 11.5 percent of the population of 1.3 billion people. Just 25 million have had two shots.
- Fear and confusion -
On Saturday the programme was expanded to all Indians over 18, equating to around 600 million people, even though many states said they have insufficient stocks to do so.
Millions of younger people terrified by the current situation and desperate to get inoculated registered on the government's digital platform.
Further confusion has been created by New Delhi's decision to ask states and private hospitals to order vaccine supplies on their own, creating a three-tier pricing system that requires them to pay more per dose than the central government.
This has led to squabbles between the central government, run by Prime Minister Narendra Modi's Bharatiya Janata Party, and states governed by opposition parties.
Anecdotal evidence suggests that some private clinics have been told they won't receive any vials for months.
"The whole thing looks like a confused elephant to me right now," said T Jacob John, a retired clinical virology professor at the Christian Medical College Vellore.
"Do you want to control the epidemic, save lives or both? If you want both you'll require a huge amount of vaccines. And we don't have it," John told AFP.
He and other experts say that given the shortages, and its colossal population, India should have a much more targeted policy, concentrating vaccinations in hotspots.
Gujarat is among the few states to have said they would do so, with chief minister Vijay Rupani saying Friday that vaccinations for over-18s would happen only in the 10 worst-hit districts.
Serum is making 60-70 million AstraZeneca doses per month, and is aiming for 100 million by July. Bharat is aiming to produce 10 million a month and targets 60-70 million.
Indian firms also have deals to produce other shots including Russia's Sputnik V -- some doses of which were due to arrive soon -- and Johnson & Johnson's single-dose vaccine, but it could be months until these are deployed.